China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Ending Cash Position : ¥3,110 Mil (As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Ending Cash Position?

China Resources Double-Crane Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥3,110 Mil.

China Resources Double-Crane Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2024 (¥2,699 Mil) to Dec. 2024 (¥2,838 Mil) and increased from Dec. 2024 (¥2,838 Mil) to Mar. 2025 (¥3,110 Mil).

China Resources Double-Crane Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2022 (¥2,615 Mil) to Dec. 2023 (¥3,208 Mil) but then declined from Dec. 2023 (¥3,208 Mil) to Dec. 2024 (¥2,838 Mil).

China Resources Double-Crane Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Ending Cash Position Chart

China Resources Double-Crane Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,491.33

1,885.13

2,614.88

3,208.14

2,838.12

China Resources Double-Crane Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															3,909.80	2,266.38	2,698.85	2,838.12	3,110.20

China Resources Double-Crane Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

China Resources Double-Crane Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3208.144	+	-370.029
	=	2,838

China Resources Double-Crane Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2838.115	+	272.089
	=	3,110

China Resources Double-Crane Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Double-Crane Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102

Website

http://www.dcpc.com

China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

Executives

Yu Shun Ting	Director
Han Shuo	senior management
Liu Zi Qin	senior management
Fan Yan Xi	senior management
Lu Wen Chao	Directors, senior managers
Man Chao	senior management
Ni Jun	senior management
Feng Yi	Director
Zheng Ze Ping	Supervisors
Li Ying	senior management

China Resources Double-Crane Pharmaceutical Co Headlines

No Headlines